Their findings demonstrated that advanced liver fibrosis (elevated FIB-4) in NAFLD patients was associated with tau pathology in AD-vulnerable regions, including the parahippocampal gyri, inferior temporal regions and rhinal areas, while Aβ deposition was observed in specific areas such as the inferior temporal and parahippocampal regions [25, 26]. This evidence concerns the gene MAPT and Alzheimer disease.